- Several Hong Kong stock companies in autonomous driving, innovative drugs, and high-end manufacturing are adjusting strategies and advancing capital operations.
- Key updates include Lepu Biopharma achieving positive phase III trial results and JL Mag securing a robotics motor rotor project with a 50 % net profit increase.
- Additional developments feature Maxieye Technology completing a 78 million HKD placement for overseas expansion and several firms navigating market fluctuations.
